FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Teva Pharmaceuticals Qnasl Recall

Qnasl (beclomethasone dipropionate) Nasal Aerosol 40 Mcg, 60 Metered Sprays, Rx only, M…

Teva Pharmaceuticals USA · North Wales, PA

Risk level
Class III
Reported by FDA
Dec 14, 2016
Recall ID
D-0170-2017
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Qnasl starting Nov 1, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0170-2017 on Dec 14, 2016. Reason: Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing. Status: Terminated.

Why it was recalled

Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.

Product description

Qnasl (beclomethasone dipropionate) Nasal Aerosol 40 Mcg, 60 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-206-06 and 59310-206-08 (Physician Samples).

Lot numbers, UPCs & expiration codes

Lot #: 150096, Exp. 3/2017; Lot #: 150327, Exp. 10/2017

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0170-2017
Classification
Class III
Status
Terminated
Recall initiated
Nov 1, 2016
FDA report date
Dec 14, 2016
Quantity
201, 234 Canisters
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-0170-2017, exactly as published.

Show all FDA fields
City
North Wales
State
PA
Status
Terminated
Country
United States
Event ID
75565
Address
1090 Horsham Rd
Code information
Lot #: 150096, Exp. 3/2017; Lot #: 150327, Exp. 10/2017
Postal code
19454-1505
Report date
Dec 14, 2016
Product type
Drugs
Recall number
D-0170-2017
Classification
Class III
Recalling firm
Teva Pharmaceuticals USA
Product quantity
201, 234 Canisters
Termination date
Feb 6, 2018
Reason for recall
Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Qnasl (beclomethasone dipropionate) Nasal Aerosol 40 Mcg, 60 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-206-06 and 59310-206-08 (Physician Samples).
Distribution pattern
Nationwide
Recall initiation date
Nov 1, 2016
Initial firm notification
Letter
Center classification date
Dec 8, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0170-2017, published Dec 14, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls